Medical Health Cluster

vaccine

THE ISTH RELEASES INTERIM GUIDANCE ON VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA (VITT)

CHAPEL HILL, NC, USA, (April 20, 2021) – As a complement to its recent statement on blood clots associated with COVID-19 vaccination, the International Society on Thrombosis and Haemostasis (ISTH) has issued interim guidance for the diagnosis and treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT). This guidance, which builds upon the work […]

Read More

Hospital admissions due to COVID-19 in Scotland after one dose of vaccine

The BNT162b2 mRNA vaccine from Pfizer–BioNTech and the ChAdOx1 nCoV-19 vaccine from Oxford–AstraZeneca were the first two products deployed in the UK’s COVID-19 vaccination programme. In accordance with the strategy set by the nation’s Joint Committee on Vaccination and Immunisation (JCVI), vaccines were initially prioritised for care home residents and […]

Read More

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021

Summary What is already known about this topic? On April 13, 2021, CDC and the Food and Drug Administration (FDA) recommended pausing use of the Janssen COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome (TTS) among vaccine recipients. What is added by this report? On April 23, the Advisory […]

Read More